Publications | Lund University Publications

1 – 5 of 5

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Erikstein%2C+B%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Erikstein%2C+B%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2007
Mark Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy
Wilking, N. ; Lidbrink, E. ; Wiklund, T. ; Erikstein, B. ; Lindman, H. ; Malmström, Per ^LU ; Kellokumpu-Lehtinen, P. ; Bengtsson, N. -O. ; Soederlund, G. and Anker, G. , et al. (2007) In Annals of Oncology 18(4). p.694-700
- Contribution to journal › Article
2005
Mark Topoisomerase IIa gene amplification predicts favorable outcome of tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2 positive breast cancer. Results from the randomized trial SBG 9401.
Tanner, MM ; Isola, JJ ; Wiklund, T ; Erikstein, B ; Kellokumpu-Lehtinen, P ; Malmström, Per ^LU ; Wilking, N ; Nilsson, J and Bergh, J (2005) 2005 ASCO Annual Meeting In Journal of Clinical Oncology 23(16S). p.841-841
- Contribution to journal › Published meeting abstract
Mark Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
Abe, O ; Abe, R ; Enomoto, K ; Kikuchi, K ; Koyama, H ; Masuda, H ; Nomura, Y ; Sakai, K ; Sugimachi, K and Tominaga, T , et al. (2005) In The Lancet 365(9472). p.1687-1717
- Contribution to journal › Article
2000
Mark Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer : a randomised trial
Bergh, J ; Wiklund, T ; Erikstein, B ; Lidbrink, E ; Lindman, H ; Malmström, Per ^LU ; Kellokumpu-Lehtinen, P ; Bengtsson, N O ; Söderlund, G and Anker, G , et al. (2000) In The Lancet 356(9239). p.1384-1391
- Contribution to journal › Article
1998
Mark Dosage of adjuvant G-CSF (filgrastim)-supported FEC polychemotherapy based on equivalent haematological toxicity in high-risk breast cancer patients. Scandinavian Breast Group, Study SBG 9401
Bergh, J ; Wiklund, T ; Erikstein, B ; Fornander, T ; Bengtsson, N O ; Malmström, P ^LU ; Kellokumpu-Lehtinen, P ; Anker, G ; Bennmarker, H and Wilking, N ^LU (1998) In Annals of oncology : official journal of the European Society for Medical Oncology 9(4). p.403-411
- Contribution to journal › Article